RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Productivity Losses Among Treated Depressed Patients Relative to Healthy Controls
Curkendall, S., Ruiz, K., Joish, V., & Mark, T. (2010). Productivity Losses Among Treated Depressed Patients Relative to Healthy Controls. Journal of Occupational and Environmental Medicine, 52(2), 152-130. https://doi.org/10.1097/JOM.0b013e3181ce10a8
Objectives: Estimate the productivity-related cost of depression in an employed population.
Methods: By using administrative data, annual short-term disability (STD) and absenteeism costs ($2005) were compared for patients with depression and treated with antidepressants and for a matched control group without depression.
Results: Mean annual STD costs were $1038 among treated depressed patients versus $325 among controls and $1685 among a subgroup of severely depressed treated patients versus $340 among their controls. After controlling for demographic and employment characteristics, treated patients with depression had STD costs that were $356 higher per patient and those with severe depression had costs that were $861 higher. The marginal impact of treated depression on absenteeism was $377.
Conclusions: Even when depressed patients are treated with antidepressants, there are substantial productivity losses. Therapies that can better manage depression may provide opportunities for savings to employers.
